SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
Document/Exhibit Description Pages Size 1: F-10 Registration Statement of a Foreign Private Issuer HTML 1.14M (Not Effective Immediately) 2: EX-3.1 Articles of Angiotech Pharmaceuticals, Inc. HTML 331K 11: EX-3.10 Memorandum and Articles of Association HTML 195K 12: EX-3.11 Memorandum and Articles of Association HTML 180K 13: EX-3.12 Memorandum and Articles of Association HTML 180K 14: EX-3.13 Memorandum and Articles of Association HTML 180K 15: EX-3.14 Memorandum and Articles of Association HTML 180K 16: EX-3.15 Order of Amalgamation HTML 201K 17: EX-3.16 Partnership Agreement HTML 184K 18: EX-3.17 Order of Amalgamation HTML 200K 19: EX-3.18 Certificate of Merger of Afmedica, Inc. HTML 38K 20: EX-3.19 Bylaws of Afmedica, Inc. HTML 127K 3: EX-3.2 Articles of 0741693 B.C. Ltd. HTML 252K 21: EX-3.20 Certificate of Incorporation HTML 41K 22: EX-3.21 Amended and Restated Bylaws HTML 65K 23: EX-3.22 Certificate of Incorporation HTML 40K 24: EX-3.23 Bylaws of American Medical Instruments, Inc. HTML 60K 25: EX-3.24 Certificate of Incorporation HTML 95K 26: EX-3.25 Bylaws of Angiotech Biocoatings Corp. HTML 52K 27: EX-3.26 Articles of Organization HTML 32K 28: EX-3.27 Operating Agreement HTML 62K 29: EX-3.28 Amended and Restated Articles of Incorporation HTML 45K 30: EX-3.29 Bylaws of Angiotech Pharmaceuticals (Us), Inc. HTML 62K 4: EX-3.3 Articles of 0761717 B.C. Ltd. HTML 283K 31: EX-3.30 Certificate of Incorporation HTML 42K 32: EX-3.31 Bylaws of B.G. Sulzle, Inc. HTML 59K 33: EX-3.32 Articles of Organization HTML 43K 34: EX-3.33 Operating Agreement HTML 118K 35: EX-3.34 Certificate of Incorporation HTML 42K 36: EX-3.35 Bylaws of Manan Medical Products, Inc. HTML 60K 37: EX-3.36 Certificate of Incorporation HTML 40K 38: EX-3.37 Bylaws of Medical Device Technologies, Inc. HTML 59K 39: EX-3.38 Certificate of Merger HTML 38K 40: EX-3.39 Bylaws of of Neucoll, Inc. HTML 64K 5: EX-3.4 Memorandum and Articles of Association HTML 180K 41: EX-3.40 Articles of Incorporation HTML 36K 42: EX-3.41 Bylaws of Point Technologies, Inc. HTML 50K 43: EX-3.42 Certificate of Incorporation HTML 42K 44: EX-3.43 Bylaws of Surgical Specialties Corporation HTML 60K 45: EX-3.44 Certificate of Incorporation HTML 59K 46: EX-3.45 Bylaws of Quill Medical, Inc. HTML 120K 47: EX-3.46 Certificate of Incorporation HTML 43K 48: EX-3.47 Amended and Restated Bylaws HTML 61K 49: EX-3.48 Memorandum and Amended Articles of Association HTML 81K 50: EX-3.49 Memorandum & Articles of Association HTML 177K 6: EX-3.5 Memorandum and Articles of Association HTML 180K 51: EX-3.50 Memorandum & Articles of Association HTML 177K 7: EX-3.6 Memorandum and Articles of Association HTML 180K 8: EX-3.7 Memorandum and Articles of Association HTML 195K 9: EX-3.8 Memorandum and Articles of Association HTML 195K 10: EX-3.9 Memorandum and Articles of Association HTML 195K 52: EX-4.1 Indenture HTML 658K 53: EX-4.2 Supplemental Indenture HTML 42K 54: EX-5.1 Opinion of Sullivan & Cromwell LLP, Special Us HTML 34K Counsel 55: EX-5.2 Opinion of Irwin, White & Jennings, British HTML 40K Columbia Counsel 56: EX-5.3 Opinion of Stewart McKelvey, Nova Scotia Counsel HTML 43K 57: EX-5.4 Opinion of Lionel Sawyer & Collins, Nevada Counsel HTML 33K 58: EX-5.5 Opinion of Heller Ehrman White & McAuliffe LLP, HTML 57K Washington Counsel 59: EX-5.6 Opinion of Faegre & Benson LLP, Colorado Counsel HTML 42K 60: EX-5.7 Opinion of McConnell Valdes, Puerto Rico Counsel HTML 41K 61: EX-5.8 Opinion of Herbert Smith LLP, England & Wales HTML 74K 62: EX-23.1 Consent of Ernst & Young LLP HTML 29K 63: EX-23.2 Consent of Pricewaterhousecoopers LLP HTML 27K 64: EX-23.3 Consent of Hughes Pittman and Gupton LLP HTML 28K 65: EX-25.1 Statement of Eligibility of the Trustee on Form HTML 67K T-1 66: EX-99.1 Letter of Transmittal HTML 114K 67: EX-99.2 Notice of Guaranteed Delivery HTML 38K
Consent of Ernst & Young LLP |
Exhibit 23.1
[LETTERHEAD OF ERNST & YOUNG LLP]
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Independent Accountants” in the Registration Statement (Forms F-10, F-4 and S-4) and related Prospectus of Angiotech Pharmaceuticals, Inc. for the registration of US$250,000,000 7.75% Senior Subordinated Notes due 2014, and to the incorporation by reference therein of our report dated February 10, 2006, except as to note 17b(iii) as to which the date is February 24, 2006, with respect to the consolidated financial statements of Angiotech Pharmaceuticals, Inc., and our report dated February 10, 2006 with respect to Angiotech Pharmaceuticals, Inc. management’s assessment of the effectiveness of internal control over financial reporting, and the effectiveness of internal control over financial reporting of Angiotech Pharmaceuticals, Inc., included in Exhibit 2 of its Annual Report (Form 40-F) for the year ended December 31, 2005, filed with the Securities and Exchange Commission and our report dated February 10, 2006, except as to note 17b(iii) as to which the date is February 24, 2006 and note 22 as to which the date is September 13, 2006, with respect to the consolidated financial statements of Angiotech Pharmaceuticals, Inc. included in its Report of Foreign Private Issuer (Form 6-K) for the year ended December 31, 2005, furnished to the Securities and Exchange Commission.
Vancouver, Canada | /s/ Ernst & Young LLP | |
October 24, 2006 | Chartered Accountants |
This ‘F-10’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed as of: | 10/25/06 | 6-K, F-X | ||
Filed on: | 10/24/06 | 6-K | ||
9/13/06 | ||||
2/24/06 | 6-K | |||
2/10/06 | ||||
12/31/05 | 40-F, 6-K | |||
List all Filings |